Artwork

Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly]

2:59
 
Distribuie
 

Manage episode 433875456 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.

Up this week:

The good — Amneal gets FDA nod for Parkinson’s pill

The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure

The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy

  continue reading

65 episoade

Artwork
iconDistribuie
 
Manage episode 433875456 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.

Up this week:

The good — Amneal gets FDA nod for Parkinson’s pill

The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure

The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy

  continue reading

65 episoade

Alle episoder

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință